Heart Failure Management in Azerbaijan

The Clinical Profiles and Treatment Management of Chronic Heart Failure in Azerbaijan

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03390088

Acronym

CHF-AZ

Enrollment

Registered

2018-01-04

Start date

2018-01-28

Completion date

2020-01-14

Last updated

2020-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

Heart failure

Brief summary

This study is proposed to determined a national database of the etiologies, clinical and the demographic profile, using diagnostic tests and treatment of outpatients with chronic heart failure in Azerbaijan population.

Detailed description

Chronic heart failure remains the leading cause of hospitalization for those over the age of 65 and expected to increase over the next 25 years with advancing life span. Being a progressive syndrome, CHF decreases the quality of life and place an economic burden on health care system. Advanced technologies in interventional cardiology, better organization of angiographic laboratories and primary prevention of coronary artery disease as the leading cause of HF, allowed warning its development in CAD patients. But the incidence and prevalence of CHF continue to increase with age as heart failure with preserved ejection fraction predominates in elderly patients. For the moment more than 23 million people over the world suffer from heart failure. The prevalence of these patients remains very high even in USA - over 5.8 million.However, there is no any database for heart failure patient in Azerbaijan.The purpose of this study is to compose a national database of the etiologies, clinical and demographic characteristics, using diagnostic tests and management of outpatients heart failure in Azerbaijan population.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Yes

Inclusion criteria

Inclusion : * Patients \>18 years olds * Clinical diagnosis of heart failure * NYHA class II-IV heart failure Exclusion : * Patients \<18 years old * Failure to obtain informed consent * Pregnant or lactating Previous cardiac transplantation

Design outcomes

Primary

Measure	Time frame	Description
Heart failure related hospitalization	6 months	Heart failure related hospitalization within 6 months

Countries

Azerbaijan

Outcome results